These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 29176691)
1. Midkine derived from cancer-associated fibroblasts promotes cisplatin-resistance via up-regulation of the expression of lncRNA ANRIL in tumour cells. Zhang D; Ding L; Li Y; Ren J; Shi G; Wang Y; Zhao S; Ni Y; Hou Y Sci Rep; 2017 Nov; 7(1):16231. PubMed ID: 29176691 [TBL] [Abstract][Full Text] [Related]
2. CAF-derived midkine promotes EMT and cisplatin resistance by upregulating lncRNA ST7-AS1 in gastric cancer. Yang KD; Wang Y; Zhang F; Li QL; Luo BH; Feng DY; Zeng ZJ Mol Cell Biochem; 2022 Nov; 477(11):2493-2505. PubMed ID: 35588343 [TBL] [Abstract][Full Text] [Related]
3. A novel stromal lncRNA signature reprograms fibroblasts to promote the growth of oral squamous cell carcinoma via LncRNA-CAF/interleukin-33. Ding L; Ren J; Zhang D; Li Y; Huang X; Hu Q; Wang H; Song Y; Ni Y; Hou Y Carcinogenesis; 2018 Mar; 39(3):397-406. PubMed ID: 29346528 [TBL] [Abstract][Full Text] [Related]
4. Silencing of long non-coding RNA ANRIL inhibits the development of multidrug resistance in gastric cancer cells. Lan WG; Xu DH; Xu C; Ding CL; Ning FL; Zhou YL; Ma LB; Liu CM; Han X Oncol Rep; 2016 Jul; 36(1):263-70. PubMed ID: 27121324 [TBL] [Abstract][Full Text] [Related]
5. LncRNA SNHG12 in extracellular vesicles derived from carcinoma-associated fibroblasts promotes cisplatin resistance in non-small cell lung cancer cells. Tan D; Li G; Zhang P; Peng C; He B Bioengineered; 2022 Jan; 13(1):1838-1857. PubMed ID: 35014944 [TBL] [Abstract][Full Text] [Related]
6. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression. Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238 [TBL] [Abstract][Full Text] [Related]
7. Effect of lncRNA ANRIL knockdown on proliferation and cisplatin chemoresistance of osteosarcoma cells in vitro. Li G; Zhu Y Pathol Res Pract; 2019 May; 215(5):931-938. PubMed ID: 30777616 [TBL] [Abstract][Full Text] [Related]
8. LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression. Wang X; Li H; Shi J Biomed Res Int; 2019; 2019():8645153. PubMed ID: 31275988 [TBL] [Abstract][Full Text] [Related]
9. ANRIL promotes chemoresistance via disturbing expression of ABCC1 by regulating the expression of Let-7a in colorectal cancer. Zhang Z; Feng L; Liu P; Duan W Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30279206 [TBL] [Abstract][Full Text] [Related]
10. Exosomal LINC00355 derived from cancer-associated fibroblasts promotes bladder cancer cell resistance to cisplatin by regulating miR-34b-5p/ABCB1 axis. Luo G; Zhang Y; Wu Z; Zhang L; Liang C; Chen X Acta Biochim Biophys Sin (Shanghai); 2021 Apr; 53(5):558-566. PubMed ID: 33720323 [TBL] [Abstract][Full Text] [Related]
11. Downregulation of midkine induces cisplatin resistance in human oral squamous cell carcinoma. Ota T; Jono H; Ota K; Shinriki S; Ueda M; Sueyoshi T; Nakatani K; Hiraishi Y; Wada T; Fujita S; Obayashi K; Shinohara M; Ando Y Oncol Rep; 2012 May; 27(5):1674-80. PubMed ID: 22344722 [TBL] [Abstract][Full Text] [Related]
12. Effects of lncRNA ANRIL on proliferation and apoptosis of oral squamous cell carcinoma cells by regulating TGF-β/Smad pathway. Liu L; Ning SB; Fu S; Mao Y; Xiao M; Guo B Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6194-6201. PubMed ID: 31364119 [TBL] [Abstract][Full Text] [Related]
13. Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19. Ren J; Ding L; Zhang D; Shi G; Xu Q; Shen S; Wang Y; Wang T; Hou Y Theranostics; 2018; 8(14):3932-3948. PubMed ID: 30083271 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance. Zhang XW; Bu P; Liu L; Zhang XZ; Li J Biochem Biophys Res Commun; 2015 Jul; 462(3):227-32. PubMed ID: 25956062 [TBL] [Abstract][Full Text] [Related]
15. Cancer-associated fibroblasts promote cisplatin resistance in bladder cancer cells by increasing IGF-1/ERβ/Bcl-2 signalling. Long X; Xiong W; Zeng X; Qi L; Cai Y; Mo M; Jiang H; Zhu B; Chen Z; Li Y Cell Death Dis; 2019 May; 10(5):375. PubMed ID: 31076571 [TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA CCAL transferred from fibroblasts by exosomes promotes chemoresistance of colorectal cancer cells. Deng X; Ruan H; Zhang X; Xu X; Zhu Y; Peng H; Zhang X; Kong F; Guan M Int J Cancer; 2020 Mar; 146(6):1700-1716. PubMed ID: 31381140 [TBL] [Abstract][Full Text] [Related]
18. Cancer-associated fibroblasts contribute to cisplatin resistance by modulating ANXA3 in lung cancer cells. Wang L; Li X; Ren Y; Geng H; Zhang Q; Cao L; Meng Z; Wu X; Xu M; Xu K Cancer Sci; 2019 May; 110(5):1609-1620. PubMed ID: 30868675 [TBL] [Abstract][Full Text] [Related]
19. Melanoma-derived exosomes induce reprogramming fibroblasts into cancer-associated fibroblasts via Gm26809 delivery. Hu T; Hu J Cell Cycle; 2019 Nov; 18(22):3085-3094. PubMed ID: 31544590 [TBL] [Abstract][Full Text] [Related]
20. LINC00511 knockdown prevents cervical cancer cell proliferation and reduces resistance to paclitaxel. Mao BD; Xu P; Xu P; Zhong Y; Ding WW; Meng QZ J Biosci; 2019 Jun; 44(2):. PubMed ID: 31180057 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]